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and growth factors, such as insulin or 
VEGF, and can be transduced via diff erent 
postreceptor signaling pathways. 8 Kajimoto 
 et al. 3 showed that treatment of human 
umbilical vein endothelial cells with ADMA 
in high- l -NAME culture conditions leads 
to a dose-dependent decrease in both basal 
and VEGF-stimulated activation of eNOS 
via Ser1177 phosphorylation. Th e pathway 
leading to Ser1177 phosphorylation of 
eNOS in response to VEGF engages the 
VEGF2 receptors insulin receptor sub-
strate-1 (IRS-1) and phosphatidylinositol-
3  -kinase (PI3K) / Akt. However, in this 
study, Akt activation induced by VEGF 
treatment was not inhibited by ADMA. 
Another pathway, documented in glomer-
ular endothelial cells by Feliers  et al. , 
involves activation of PI3K and extracellu-
lar signal-regulated kinases 1 and 2 
(ERK1 / 2); 9 and Kajimoto  et al. 3 report inhi-
bition of ERK1 / 2 activation by ADMA. 
 Although these data require substantial 
validation by molecular and pharmaco-
logical manipulation of the various kinases, 
it is tempting to speculate that ADMA may 
have a selective inhibitory rather than a 
promiscuous toxic effect on signaling 
kinases, leading to decreased eNOS activa-
tion ( Figure 1 ). Also, follow-up studies that 
comprehensively examine all of the known 
eNOS phosphorylation sites and the signal-
ing molecules engaged in response to 
diff erent agonists are critical to understand 
the potentially complex eff ects of ADMA 
on eNOS activation. For example, a prom-
ising candidate may be Ser144, which is 
phosphorylated by ERK1 / 2, resulting in an 
altered ability of eNOS to bind the prolyl 
isomerase Pin1, which in turn negatively 
impacts eNOS activity. 10 
 Understanding which signaling path ways 
leading to reduced eNOS activity are 
aff ected by ADMA may lead in the future 
to the design of better therapies to reduce 
the effects of ADMA in addition to the 
current eff orts to minimize ADMA accu-
mulation in CKD and other patho logical 
conditions. Therefore, the study by 
Kajimoto  et al. 3 is important, as it opens 
new avenues to investigate molecular 
mechanisms responsible for vascular and 
renal eff ects of ADMA via eNOS inhibition 
beyond the old rivalry between ADMA 
and  l -arginine as substrates of choice for 
catalysis by eNOS. 
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 Patients with end-stage renal disease who 
require long-term hemodialysis need a 
reliable vascular access. Th e arterio venous 
fi stula is the access of choice owing to its 
long patency rate and low complication 
profi le. 1 It is created by the direct anasto-
mosis of adjacent artery and vein. Fistulae 
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 The arteriovenous fistula is the preferred vascular access for 
hemodialysis patients because of its low complication rate and lower 
costs, but it still has unacceptable failure rates. Krishnamoorthy  et al. 
implicate the geometry of the fistula in the temporal and spatial 
variations occurring in two of the most important parameters of 
fistula maturation, blood flow and vessel diameter. 
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capable of maintaining a minimum blood 
fl ow rate between 450 and 500  ml / min are 
considered  ‘ mature ’ and suitable for dialy-
sis. Th e problem resides in that many fi s-
tulae fail to mature (up to 66 % at 2 years). 2 
In fact, arteriovenous fi stula failure is the 
most important cause of morbidity in the 
hemodialysis population, which is cur-
rently more than 300  000 in the United 
States alone. 3 Despite the magnitude of the 
problem, there have been no major 
advances in the field of hemodialysis 
vascular access for the past three decades, 
and only a modest increased rate of schol-
arly activity in this area has been lately 
seen. 4 Th erefore, there is still an unmet 
necessity of basic studies to assess the role 
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of hemodynamics, anatomy, and biology 
in arteriovenous fi stula maturation. 
 Krishnamoorthy  et al. 5 (this issue) deal 
once again with the apparently simple but 
complex relationship between the basic ana-
tomic shape of the fi stula and two important 
parameters of fistula maturation, blood 
flow and diameter. Using ultrasound 
and computed tomographic scan, these 
authors measured temporal changes in 
configu ration, internal diameter, and 
blood fl ow occurring in straight and curved 
fi stulae that were created in experimental 
pigs ( Figure 1 ). Th ey revealed the superior-
ity of the curved over the straight fi stula 
to deliver higher venous diameters and 
blood fl ood rates at 28 days aft er surgery. 
Th ese outcomes are broadly in line with 
those previously reported by this team (Roy-
Chaudhury ’ s team) when they described 
how the complex patters of wall shear stress 
within the venous limb of the fi stula deter-
mined the pathological remodeling of the 
vessel wall. 6,7 On that occasion, they calcu-
lated a complete wall stress profi le for the 
curved confi guration and correlated it with 
luminal stenosis. Th ey found a profound 
relationship between the wall shear stress 
profi le of the curved and straight fi stula and 
the histological architecture of the vessel. 
Interestingly, there was a local wall shear 
stress variation with time at outer and inner 
walls of both fistulae that explained the 
eccentric histological pattern of intima –
 media thickening found in the failed 
fi stula. Undoubtedly, in these studies Roy-
Chaudhury ’ s team have created suffi  cient 
grounds for a human study aimed at proving 
the impact of surgical configuration on 
fistula failure, whose outcomes could 
help confi gure better parameters to facilitate 
long-term fi stula patency. In fact, since the 
fi rst description of a side-to-side anastomo-
sis between radial artery and cephalic 
vein in the wrist by Brescia  et al. , 8 very few 
modifi cations in the basic type of anasto-
mosis have been made. Perhaps the major 
change was the introduction of the side-
to-end (artery-to-vein) anastomosis. Th is 
type of anastomosis has the advantage that 
it is technically feasible even in cases in 
which the distance between the artery and 
the vein does not permit side-to-side anas-
tomosis. Another advantage of the side-to-
end anastomosis is the lower risk of venous 
hyper tension and swelling of the hand. 
 It is important to note that the work 
of Krishnamoorthy  et al. 5 becomes rele-
vant in the absence of studies intended to 
elucidate how geometric and hemo-
dynamic factors such as anastomosis 
length and angle, vessel diameter, and fl ow 
distribution patterns determine fi stula 
maturation. Only a few attempts have 
been made to assess the impact of fi stula 
geometry on stenosis in hemodialysis 
patients. Perhaps one of the most repre-
sentative studies is that published by 
Sivanesan  et al. more than a decade ago. 9 
Th is team identifi ed sites of stenosis in 
radiocephalic arteriovenous fi stulae and 
related the fi ndings to various clinical and 
geometrical parameters. Th ey measured 
postoperatively the anastomotic length 
and angle in 25 consecutive fi stulae using 
duplex and color-fl ow ultrasono graphy. In 
agreement with the data of Krishnamoor-
thy  et al. , 5 this report identifi ed stenosis 
that developed just proximal to the curved 
segment of the cephalic vein where the 
vein straightens out as the most aggressive 
and progressive stenosis. 
 It is important also to note that the study 
by Krishnamoorthy  et al. 5 has its own 
limitations. One is the lack of chronic kid-
ney disease in the experimental model, 
which is a deleterious factor for vascular 
remodeling. 10 Th is can be a minor issue if 
it is taken into consideration that histo-
logical lesions developed in non-uremic 
pigs are quite similar to those seen in 
human tissues. 11 A second limitation is the 
lack of histological examination in curved 
and straight fi stulae to establish the cause – 
eff ect relationship between the variations 
in blood fl ow and diameter and the archi-
tecture of the vessel. Nonetheless, these 
authors have previously shown that fi stula 
configuration indeed is translated into 
histological diff erences. 6 A third limitation 
is that pig fi stulae lack the collateral veins 
or tributaries that in humans help dissipate 
pressure in the presence of an outflow 
obstruction and prevent a marked increase 
in pressures. Branches also in evitably pro-
duce fl ow disturbances and regions of fl ow 
separation that can potentially modify the 
development of stenotic lesions. 
 In conclusion, this study evidences that 
the geometric conformation of the fi stula 
can determine its successful maturation. 
Now, is it time to modify the basic anasto-
motic design of the fi stula? What would be 
the impact on maturation if newly native 
fi stulae included curvatures in the proximal 
region of the vein? For now the answers 
remain uncertain, but the findings of 
Krishnamoorthy  et al. 5 warrant future stud-
ies to demonstrate the plausibility of 
designing an optimal anatomic confi gura-
tion for human fi stulae that minimizes the 
failure rate. If this can be achieved, new rec-
ommendations and scientifi cally validated 
approaches that optimize fi stula geometry 
while ensuring a proper and timely matura-
tion of the fi stula are foreseen ( Figure 1 ). 
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• Higher flow rates 
• Higher dilatation rates and final  
   luminal diameters
• Neointimal hyperplasia with a minimum
   in tima–media thickness ratio
• Lower flow rates 
• Smaller luminal diameters
• Greater differences in wall shear stress
  at the outer and inner vascular walls  
• More eccentric neointimal hyperplasia
 Figure 1  |  Characteristics of curved and straight fistulae.  Arrows indicate the direction of blood 
flow. DA, distal artery; PA, proximal artery; PV, proximal vein. 
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